Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases. (2023)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s40635-023-00554-y
PubMed Identifier: 37801184
Publication URI: http://europepmc.org/abstract/MED/37801184
Type: Journal Article/Review
Volume: 11
Parent Publication: Intensive care medicine experimental
Issue: 1
ISSN: 2197-425X